MedTrace Logo

Serum and Exhaled Breath Condensate MALDI-MS of Lung Cancer. (SPORE)

NCT00898209 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 564

Last updated 2014-06-24

No results posted yet for this study

Summary

RATIONALE: Collecting and storing samples of blood and exhaled breath from patients with cancer and from healthy participants to study in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This research study is collecting and analyzing samples of blood and exhaled breath from patients who have or are at high risk for lung cancer and from healthy participants.

Conditions

Interventions

GENETIC

protein expression analysis

Blood and exhaled breath condensate will be collected.

GENETIC

proteomic profiling

Blood and exhaled breath condensate will be collected.

OTHER

biologic sample preservation procedure

Blood and exhaled breath condensate will be collected.

OTHER

laboratory biomarker analysis

Blood and exhaled breath condensate will be collected.

OTHER

matrix-asst laser desorption/ionization time flight mass spectrometry

Blood and exhaled breath condensate will be collected.

OTHER

questionnaire administration

Questionnaire will be completed.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Vanderbilt-Ingram Cancer Center

    lead OTHER

Principal Investigators

  • Pierre P. Massion, MD · Vanderbilt-Ingram Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-04-30
Primary Completion
2009-02-28
Completion
2009-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00898209 on ClinicalTrials.gov